Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma

• Main Authors: Xianlong Chen (Author), Shengwei Mo (Author), Yue Zhang (Author), Heng Ma (Author), Zhaohui Lu (Author), Shuangni Yu (Author), Jie Chen (Author)
• Format: Book
• Published: Wiley, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Siglec‐15, a novel immune checkpoint, is an emerging target for next‐generation cancer immunotherapy. However, the role of Siglec‐15 in pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. We investigated the expression of Siglec‐15 and its association with clinicopathological...